SoftBank Group, through its affiliate, sold shares worth more than Rs 1,896 crore in multinational eyewear maker Lenskart Solutions, while Nirma, the promoter of Alivus Life Sciences (formerly Glenmark Life Sciences), offloaded a 2.3 percent stake in the company through open-market transactions on November 6.
In terms of stock performance, Lenskart shares rose 0.89 percent to close at Rs 724.75, while Alivus Life Sciences shares declined 1.11 percent to Rs 1,480.60 amid heavy trading volumes.
According to block deal data, SVF II Lightbulb (Cayman), an affiliate of Japanese investment holding company SoftBank Group, sold a 1.56 percent stake in Lenskart, equivalent to 2.72 crore shares, for Rs 1,896.2 crore.
The stake sale represented a portion of SoftBank's 7.27 percent holding in the company, as per its latest shareholding pattern.
A total of 13 domestic and global institutional investors acquired all the shares offloaded by SoftBank through block deals at Rs 697.15 apiece.